CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 16 enrolled
Drug / intervention
Micronutrientdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05268744
NCT05268744Phase 2Completed
CompareCT.gov

Micronutrient Supplementation in Children With Autism Spectrum Disorder (ASD): A Clinical Trial Examining Mechanism of Action

University of California, San Francisco·interventional·Posted Mar 7, 2022·Updated Feb 29, 2024

In Brief

A Phase 2 clinical trial evaluating Micronutrient for Autism Spectrum Disorder. Completed, enrolled 16 participants across 1 site.

Detailed Summary

An open-label examination of changes in metabolites with use of micronutrients in children with autism spectrum disorder (ASD). Investigators will also measure behavioral measures monthly at school with teachers and parents report.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAutism Spectrum Disorder
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2023202420252026
First PostedMar 7, 2022
Enrollment StartNov 14, 2022
Primary CompletionJan 14, 2023
Study CompletionJan 30, 2023
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 4.3 years ago

Interventions

Micronutrientdrug

Subject will take micronutrient supplement daily for 8 weeks